Goldman Jonathan (CIK 0002013869)

Latest company ownership

AVTX - Avalo Therapeutics, Inc.

Role: Director

Shares held

8,200

Last filed at

Nov 17, 2025

Confidence Score

29.4

2025Q4

Confidence Score History

2025Q4 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 14, 2025	Nov 17, 2025	Avalo Therapeutics, Inc.	Director	Sell	22.5	-11,367	-100.00%	✗	$162.9K